Heart attack medications: ACEI or ARB for LVSD

Left ventricular systolic dysfunction (LVSD) means that the lower left pumping chamber of the heart, the left ventricle, is not pumping as efficiently as it should. Angiotensin converting enzyme inhibitors (ACEIs) and Angiotensin receptor blockers (ARBs) are medications that can be helpful for heart failure patients with LVSD.

ACEIs are recommended in patients with LVSD, and ARBs are recommended for patients with LVSD who cannot tolerate ACEIs.

These medications are an important part of treating heart attack patients who have LVSD. A higher percent of being treated with ACEIs or ARBs may indicate that a hospital provides a higher level of patient care.

About this measure

The first graph below shows the percent of heart attack patients with LVSD who were treated with ACE-Is or ARBs in the hospital. The second graph shows a trend over time for this measure.

Northwestern Memorial Hospital wants to provide the most up to date data. For this measure, our data is from a more recent time period than the benchmark time period.

Note: In this case, a higher number is better.  

Most Recent Available Data (Percent)
  2013 Q1
Northwestern Memorial 100
National Average 97
State Average 98
Performance Trend (Percent)
  2011 Q1 2011 Q2 2011 Q3 2011 Q4 2012 Q1 2012 Q2 2012 Q3 2013 Q1
Northwestern Memorial 100 100 92 100 100 100 100 100
National Average 96 96 96 96 97 97 97 97
State Average 96 96 96 97 97 97 98 98
Source:U.S. Department of Health & Human Services, www.hospitalcompare.hhs.gov